SOTAC PHARMACEUTICALS
Back to Income Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4.28 Cr | ₹2.88 Cr | ₹2.88 Cr | ₹-2.37 Cr | ₹0.09 Cr |
What is the latest Consolidated Net Profit of SOTAC PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹4.28 Cr |
| Mar2024 | ₹2.88 Cr |
| Mar2023 | ₹2.88 Cr |
| Mar2022 | ₹-2.37 Cr |
| Mar2021 | ₹0.09 Cr |
How is Consolidated Net Profit of SOTAC PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.28 Cr | 48.65 | |
| Mar2024 | ₹2.88 Cr | 0.03 | |
| Mar2023 | ₹2.88 Cr | Positive | |
| Mar2022 | ₹-2.37 Cr | Negative | |
| Mar2021 | ₹0.09 Cr | - | |
Compare Consolidated Net Profit of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -5.3% | -15.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.3% |
-15.1% |
-25.9% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses